Blocking SPTBN1, through an SPTBN1-specific siRNA, blocks ammonia toxicity and restores normal SMAD3/TGF-β signaling by reducing the abundance of SPTBN1-cleaved fragments in SW480 and Caco-2 (CRC) cell lines. Here, SMAD3 is linked to colorectal carcinoma.